Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefits and Advantages of Intraoperative ERCP Versus Therapeutic Splitting in Cholecysto-, Choledocholithiasis in a High Expertise Center

NCT06130163 is registered in ClinicalTrials.gov with Kepler University Hospital as lead sponsor.

NCT NCT06130163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06130163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefits and Advantages of Intraoperative ERCP Versus Therapeutic Splitting in Cholecysto-, Choledocholithiasis in a High Expertise Center
Lead sponsor
Kepler University Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
June 30, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholelithiasis, common bile duct